213 related articles for article (PubMed ID: 2469545)
1. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
[TBL] [Abstract][Full Text] [Related]
2. Ventricular defibrillation in canines with chronic infarction, and effects of lidocaine and procainamide.
Ware DL; Atkinson JB; Brooks MJ; Echt DS
Pacing Clin Electrophysiol; 1993 Feb; 16(2):337-46. PubMed ID: 7680463
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of antiarrhythmic drug-induced changes in defibrillation threshold: role of potassium and sodium channel conductance.
Ujhelyi MR; Schur M; Frede T; Bottorff MB; Gabel M; Markel ML
J Am Coll Cardiol; 1996 May; 27(6):1534-42. PubMed ID: 8626970
[TBL] [Abstract][Full Text] [Related]
4. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model.
Dorian P; Wang M; David I; Feindel C
Circulation; 1991 Feb; 83(2):614-21. PubMed ID: 1991379
[TBL] [Abstract][Full Text] [Related]
5. Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devices.
Echt DS; Gremillion ST; Lee JT; Roden DM; Murray KT; Borganelli M; Crawford DM; Stewart JR; Hammon JW
J Cardiovasc Electrophysiol; 1994 Sep; 5(9):752-60. PubMed ID: 7827714
[TBL] [Abstract][Full Text] [Related]
6. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
[TBL] [Abstract][Full Text] [Related]
7. Effects of verapamil and Bay K 8644 on defibrillation energy requirements in dogs.
Schräder R; Brooks M; Echt DS
J Cardiovasc Pharmacol; 1992 Jun; 19(6):839-50. PubMed ID: 1376802
[TBL] [Abstract][Full Text] [Related]
8. Effects of lidocaine, ajmaline, and diltiazem on ventricular defibrillation energy requirements in isolated rabbit heart.
Anvari A; Mast F; Schmidinger H; Schuster E; Allessie M
J Cardiovasc Pharmacol; 1997 Apr; 29(4):429-35. PubMed ID: 9156350
[TBL] [Abstract][Full Text] [Related]
9. Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis.
Villemaire C; Nattel S
Circulation; 1994 Jun; 89(6):2870-8. PubMed ID: 8205703
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements.
Dorian P; Fain ES; Davy JM; Winkle RA
J Am Coll Cardiol; 1986 Aug; 8(2):327-32. PubMed ID: 3734254
[TBL] [Abstract][Full Text] [Related]
11. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements.
Dorian P; Newman D
Cardiovasc Res; 1997 Feb; 33(2):485-94. PubMed ID: 9074714
[TBL] [Abstract][Full Text] [Related]
12. pH-dependent effects of lidocaine on defibrillation energy requirements in dogs.
Echt DS; Cato EL; Coxe DR
Circulation; 1989 Oct; 80(4):1003-9. PubMed ID: 2791234
[TBL] [Abstract][Full Text] [Related]
13. [Transthoracic defibrillation of cardiac ventricles: effects of novocainamide on effectiveness of an electric impulse of bipolar sinusoidal shape].
Vostrikov VA; Bogushevich MS; Mikhaĭlov IV
Patol Fiziol Eksp Ter; 1999; (2):23-6. PubMed ID: 10379179
[TBL] [Abstract][Full Text] [Related]
14. The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
Mehdirad AA; Carnes CA; Nelson SD
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):147-51. PubMed ID: 9990620
[TBL] [Abstract][Full Text] [Related]
15. Barium decreases defibrillation energy requirements.
Dorian P; Witkowski FX; Penkoske PA; Feder-Elituv RS
J Cardiovasc Pharmacol; 1994 Jan; 23(1):107-12. PubMed ID: 7511721
[TBL] [Abstract][Full Text] [Related]
16. Ibutilide: enhanced defibrillation via plateau sodium current activation.
Wesley RC; Farkhani F; Morgan D; Zimmerman D
Am J Physiol; 1993 Apr; 264(4 Pt 2):H1269-74. PubMed ID: 8386483
[TBL] [Abstract][Full Text] [Related]
17. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies.
Kerber RE; Pandian NG; Jensen SR; Constantin L; Kieso RA; Melton J; Hunt M
J Am Coll Cardiol; 1986 Feb; 7(2):397-405. PubMed ID: 3944361
[TBL] [Abstract][Full Text] [Related]
18. Hypertonic saline does not reverse the sodium channel blocking actions of lidocaine: evidence from electrophysiologic and defibrillation studies.
Ujhelyi MR; Schur M; Frede T; Bottorff MB; Gabel M; Markel ML
J Cardiovasc Pharmacol; 1997 Jan; 29(1):61-8. PubMed ID: 9007672
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction.
de Langen CD; Hanich RF; Michelson EL; Kadish AH; Levine JH; Balke CW; Spear JF; Moore EN
J Am Coll Cardiol; 1988 Feb; 11(2):403-13. PubMed ID: 3339181
[TBL] [Abstract][Full Text] [Related]
20. Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs.
Topham SL; Cha YM; Peters BB; Chen PS
Circulation; 1992 Mar; 85(3):1146-51. PubMed ID: 1537112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
